Cardiovascular drugs

Cardiac Drugs Used in Hypertension Used in Angina Pectoris and MI Used in Shock Used in Arrhythmias Used in CHF

Used in Hypertension

Used in Angina Pectoris and MI

Used in Shock

Used in Arrhythmias

Used in CHF

Antihypertensive drugs The Drugs employed to control hypertension can be classified as: Diuretics Beta-blockers Alpha adrenergic blockers Calcium channel blockers Angiotensin-converting enzyme inhibitors Angiotensin II receptor blockers Peripheral vasodilators

The Drugs employed to control hypertension can be classified as:

Diuretics

Beta-blockers

Alpha adrenergic blockers

Calcium channel blockers

Angiotensin-converting enzyme inhibitors

Angiotensin II receptor blockers

Peripheral vasodilators

Common Drugs in HPN IN Evaluating the effectiveness of these drugs is simply to monitor the BP if it becomes NORMAL

IN Evaluating the effectiveness of these drugs is simply to monitor the BP if it becomes NORMAL

The “olol”s The Beta-Blockers (B1) These agents are antagonist of the beta-receptors of the sympathetic nervous system. They reduce cardiac output by diminishing the sympathetic nervous system response and sympathetic tone.

The Beta-Blockers (B1)

These agents are antagonist of the beta-receptors of the sympathetic nervous system.

They reduce cardiac output by diminishing the sympathetic nervous system response and sympathetic tone.

The “olol”s The Beta-Blockers Vascular resistance and heart rate decrease causing reduced blood pressure. Beta-blockers can either block the beta- receptor, beta 2 receptor or BOTH. The selective beta-blockers (B1) are specific to one type of receptor only.

The Beta-Blockers

Vascular resistance and heart rate decrease causing reduced blood pressure. Beta-blockers can either block the beta- receptor, beta 2 receptor or BOTH.

The selective beta-blockers (B1) are specific to one type of receptor only.

The “olol”s The following are the common beta-blockers- the ‘-OLOL’ Non-selective (B1 and B2) Propranolol Carteolol Nadolol Penbutolol Pindolol Timolol Selective and Specific (B1) Acebutolol Atenolol Betaxolol Bisoprolol Metoprolol

The following are the common beta-blockers- the ‘-OLOL’

Non-selective (B1 and B2)

Propranolol

Carteolol

Nadolol

Penbutolol

Pindolol

Timolol

Selective and Specific (B1)

Acebutolol

Atenolol

Betaxolol

Bisoprolol

Metoprolol

The “olol”s Pharmacodynamics: the mechanism of action of the beta-blockers These agents block the beta-adrenergic receptors in the body, thereby decreasing the heart rate and in turn, the blood pressure.

Pharmacodynamics: the mechanism of action of the beta-blockers

These agents block the beta-adrenergic receptors in the body, thereby decreasing the heart rate and in turn, the blood pressure.

The “olol”s Pharmacodynamics: the mechanism of action of the beta-blockers. The non-selective agents block both Beta1 and 2 receptors causing bronchial constriction. The onset of action is 30 minutes and the duration may range from 6-12 hours.

Pharmacodynamics: the mechanism of action of the beta-blockers.

The non-selective agents block both Beta1 and 2 receptors causing bronchial constriction.

The onset of action is 30 minutes and the duration may range from 6-12 hours.

The “olol”s Clinical Indications of the beta-blockers Hypertension Angina pectoris Myocardial infarction

Clinical Indications of the beta-blockers

Hypertension

Angina pectoris

Myocardial infarction

The “olol”s Contraindications and precautions These agents are not given to patients with: Heart blocks Bradycardia Congestive heart failure Chronic obstructive pulmonary disease Diabetes

Contraindications and precautions

These agents are not given to patients with:

Heart blocks

Bradycardia

Congestive heart failure

Chronic obstructive pulmonary disease

Diabetes

The “olol”s Pharmacodynamics- Side effects and adverse effects CVS- Bradycardia , Hypotension, rebound hypertension when abruptly stopped Respi- Bronchoconstriction, bronchospasms Others- insomnia, depression, nightmares, constipation Impaired ability of the liver to convert glycogen to glucose causing HYPOGLYCEMIA!

Pharmacodynamics- Side effects and adverse effects

CVS- Bradycardia , Hypotension, rebound hypertension when abruptly stopped

Respi- Bronchoconstriction, bronchospasms

Others- insomnia, depression, nightmares, constipation

Impaired ability of the liver to convert glycogen to glucose causing HYPOGLYCEMIA!

The “olol”s Implementation Monitor patient’s vital signs. Take the heart rate before giving the drug Instruct the patient to take the drug as prescribed. Warn not to abruptly stop the medication Suggest to avoid over-the-counter medications Give health teaching as to name of drug, dosages and side effects.

Implementation

Monitor patient’s vital signs. Take the heart rate before giving the drug

Instruct the patient to take the drug as prescribed. Warn not to abruptly stop the medication

Suggest to avoid over-the-counter medications

Give health teaching as to name of drug, dosages and side effects.

The “olol”s Implementation Remind client NOT to change position abruptly as to avoid orthostatic Hypotension Alert diabetic clients of the possible hypoglycemic effect Inform that this can cause sexual dysfunction

Implementation

Remind client NOT to change position abruptly as to avoid orthostatic Hypotension

Alert diabetic clients of the possible hypoglycemic effect

Inform that this can cause sexual dysfunction

The “olol”s Implementation Advise client to utilize other means to control blood pressure such as diet modification, exercise, lifestyle changes, etc Advise to eat high fiber foods to counter-act constipation

Implementation

Advise client to utilize other means to control blood pressure such as diet modification, exercise, lifestyle changes, etc

Advise to eat high fiber foods to counter-act constipation

The Prils The Angiotensin Converting Enzyme Inhibitors These are commonly called ACE inhibitors because the agents BLOCK the conversion of AI to AII in the LUNGS. These agents alter one of the mechanisms of blood pressure control- the RAAS or renin-angiotensin-aldosterone system. Angiotensin II is a very powerful vasoconstrictor and stimulus for the release of aldosterone.

The Angiotensin Converting Enzyme Inhibitors

These are commonly called ACE inhibitors because the agents BLOCK the conversion of AI to AII in the LUNGS.

These agents alter one of the mechanisms of blood pressure control- the RAAS or renin-angiotensin-aldosterone system.

Angiotensin II is a very powerful vasoconstrictor and stimulus for the release of aldosterone.

The Prils The Angiotensin Converting Enzyme Inhibitors “— Pril” Benazepril Captopril- prototype Enalapril Enalaprilat Fosinopril Lisinopril Moexipril Quinapril Ramipril Trandorapril

The Angiotensin Converting Enzyme Inhibitors

“— Pril”

Benazepril

Captopril- prototype

Enalapril

Enalaprilat

Fosinopril

Lisinopril

Moexipril

Quinapril

Ramipril

Trandorapril

The Prils Pharmacodynamics: The mechanism of action of the ACE inhibitors These agents prevent the conversion of angiotensin I to angiotensin II by inhibiting the enzyme in the lungs- the angiotensin converting enzyme. The action leads to decreased AII and decreased aldosterone level leading to a decrease in blood pressure.

Pharmacodynamics: The mechanism of action of the ACE inhibitors

These agents prevent the conversion of angiotensin I to angiotensin II by inhibiting the enzyme in the lungs- the angiotensin converting enzyme.

The action leads to decreased AII and decreased aldosterone level leading to a decrease in blood pressure.

The Prils Pharmacodynamics: The mechanism of action of the ACE inhibitors The effect of lowering the blood pressure is attributed to the decrease in cardiac workload and decrease peripheral resistance and blood volume .

Pharmacodynamics: The mechanism of action of the ACE inhibitors

The effect of lowering the blood pressure is attributed to the decrease in cardiac workload and decrease peripheral resistance and blood volume .

The Prils Clinical indications of the ACE inhibitors Hypertension, either alone or in combination with other agents. Congestive heart failure, left ventricular dysfunction Diabetes

Clinical indications of the ACE inhibitors

Hypertension, either alone or in combination with other agents.

Congestive heart failure, left ventricular dysfunction

Diabetes

The Prils Contraindications and Precautions in the Use of ACE inhibitors Presence of allergy is a clear contraindication. The ACE inhibitors are NOT given to patients with renal dysfunction because these drugs may cause further decrease in renal blood flow. If given to pregnant women, the drugs cross the placenta and produce renal abnormalities in the fetus.

Contraindications and Precautions in the Use of ACE inhibitors

Presence of allergy is a clear contraindication.

The ACE inhibitors are NOT given to patients with renal dysfunction because these drugs may cause further decrease in renal blood flow.

If given to pregnant women, the drugs cross the placenta and produce renal abnormalities in the fetus.

ACE inhibitors Pharmacodynamics: the adverse effects CVS- reflex tachycardia , chest pain, angina, cardiac arrhythmias CNS- dizziness, drowsiness, and lightheadedness GIT- GI irritation, nausea, vomiting, peptic ulcer, constipation and liver damage Renal- renal insufficiency, proteinuria Others- rash, photosensitivity, dermatitis and alopecia, sodium excretion and potassium retention, fatal pancytopenia. COUGH - this cough is really unrelenting and bothersome.

Pharmacodynamics: the adverse effects

CVS- reflex tachycardia , chest pain, angina, cardiac arrhythmias

CNS- dizziness, drowsiness, and lightheadedness

GIT- GI irritation, nausea, vomiting, peptic ulcer, constipation and liver damage

Renal- renal insufficiency, proteinuria

Others- rash, photosensitivity, dermatitis and alopecia, sodium excretion and potassium retention, fatal pancytopenia.

COUGH - this cough is really unrelenting and bothersome.

ACE inhibitors Implementation The nurse should encourage the patient to implement lifestyle changes such as weight reduction, smoking cessation, decreased intake of alcohol, dietary restriction of salt/fats and increased exercise. Give the drug on an empty stomach, either 1 hour before or 2 hours after meals to ensure proper drug absorption

Implementation

The nurse should encourage the patient to implement lifestyle changes such as weight reduction, smoking cessation, decreased intake of alcohol, dietary restriction of salt/fats and increased exercise.

Give the drug on an empty stomach, either 1 hour before or 2 hours after meals to ensure proper drug absorption

ACE inhibitors Implementation Monitor the patient who is at risk of developing fluid volume alteration Provide comfort measures like safety Precaution, environmental control, skin care, oral care and symptomatic relief of cough.

Implementation

Monitor the patient who is at risk of developing fluid volume alteration

Provide comfort measures like safety Precaution, environmental control, skin care, oral care and symptomatic relief of cough.

ACE inhibitors Implementation Provide patient teaching including the name of drug, dosage, measure to handle adverse effects and the warning signs to report. Stress the importance of NOT abruptly stopping the medication if symptoms are improving . Caution the patient to change position slowly and to avoid hazardous or delicate tasks and driving if drowsiness is a problem

Implementation

Provide patient teaching including the name of drug, dosage, measure to handle adverse effects and the warning signs to report. Stress the importance of NOT abruptly stopping the medication if symptoms are improving .

Caution the patient to change position slowly and to avoid hazardous or delicate tasks and driving if drowsiness is a problem

The “sartans” The Angiotensin II Receptor Blockers These are SELECTIVE agents that specifically bind to the angiotensin II receptors in the blood vessels and adrenal cortex to prevent the release of aldosterone and to prevent vasoconstriction.

The Angiotensin II Receptor Blockers

These are SELECTIVE agents that specifically bind to the angiotensin II receptors in the blood vessels and adrenal cortex to prevent the release of aldosterone and to prevent vasoconstriction.

The “sartans” Prototype: Losartan Candesartan Irbesartan Losartan Telmisartan Valsartan

Prototype: Losartan

Candesartan

Irbesartan

Losartan

Telmisartan

Valsartan

The “sartans” Pharmacodynamics- The mechanism of action of the A-R-B These agents work by attaching to the Angiotensin II receptors in the vascular smooth muscles and in the adrenal gland. The action results in VASODILATION because AII action (constriction) is inhibited and BLOCKAGE of aldosterone release

Pharmacodynamics- The mechanism of action of the A-R-B

These agents work by attaching to the Angiotensin II receptors in the vascular smooth muscles and in the adrenal gland.

The action results in VASODILATION because AII action (constriction) is inhibited and BLOCKAGE of aldosterone release

The “sartans” Clinical Use of the A-R-B Hypertension, either alone or in combination. These agents are also used if the patient cannot tolerate the unrelenting cough associated with ACE inhibitors.

Clinical Use of the A-R-B

Hypertension, either alone or in combination.

These agents are also used if the patient cannot tolerate the unrelenting cough associated with ACE inhibitors.

The “sartans” Contraindications and precautions associated with the A-R-B These agents are contraindicated in the presence of allergy. It is NOT GIVEN to pregnant mothers because of the associated FETAL DEATH and severe fetal abnormalities. Lactating women should also avoid these drugs because they can affect the neonate.

Contraindications and precautions associated with the A-R-B

These agents are contraindicated in the presence of allergy.

It is NOT GIVEN to pregnant mothers because of the associated FETAL DEATH and severe fetal abnormalities. Lactating women should also avoid these drugs because they can affect the neonate.

The “sartans” Pharmacodynamics: the adverse effects CNS- headache, dizziness, weakness, syncope and orthostatic Hypotension GIT- Diarrhea, abdominal pain, nausea, dry mouth and tooth pain Respiratory- mild cough Skin- rash, dry skin and alopecia.

Pharmacodynamics: the adverse effects

CNS- headache, dizziness, weakness, syncope and orthostatic Hypotension

GIT- Diarrhea, abdominal pain, nausea, dry mouth and tooth pain

Respiratory- mild cough

Skin- rash, dry skin and alopecia.

The “sartans” Implementation Encourage the patient to implement lifestyle changes, including weight loss, smoking cessation, decrease in alcohol and salt in the diet, and increased exercise, to increase the effectiveness of anti-hypertensive therapy. Administer without regard to meals; give with food to decrease GI distress if needed .

Implementation

Encourage the patient to implement lifestyle changes, including weight loss, smoking cessation, decrease in alcohol and salt in the diet, and increased exercise, to increase the effectiveness of anti-hypertensive therapy.

Administer without regard to meals; give with food to decrease GI distress if needed .

The “sartans” Implementation Alert the surgeon and mark the patient's chart prominently if the patient is to undergo surgery to alert medical personnel that the blockage of compensatory angiotensin II could result in hypotension following surgery that needs to be reversed with volume expansion.

Implementation

Alert the surgeon and mark the patient's chart prominently if the patient is to undergo surgery to alert medical personnel that the blockage of compensatory angiotensin II could result in hypotension following surgery that needs to be reversed with volume expansion.

The “sartans” Implementation Ensure that the patient is not pregnant before beginning therapy and suggest the use of barrier contraceptives while on this drug to avert potential fetal death or abnormalities that have been associated the these drugs. Find an alternative method of feeding the baby if patient is nursing to prevent the potentially danger- block of the renin-angiotensin system in the neonate.

Implementation

Ensure that the patient is not pregnant before beginning therapy and suggest the use of barrier contraceptives while on this drug to avert potential fetal death or abnormalities that have been associated the these drugs.

Find an alternative method of feeding the baby if patient is nursing to prevent the potentially danger- block of the renin-angiotensin system in the neonate.

The “sartans” Implementation Monitor the patient carefully in any situation that might lead to a drop in fluid volume (e. g., excessive eating, and vomiting diarrhea, dehydration) to detect treat excessive hypotension that may occur. Provide comfort measures to help the patient tolerate drug effects (e.g., small, frequent meals; access to bathroom facilities; safety precautions if CNS effects occur environmental control; appropriate skin care needed; analgesics as needed).

Implementation

Monitor the patient carefully in any situation that might lead to a drop in fluid volume (e. g., excessive eating, and vomiting diarrhea, dehydration) to detect treat excessive hypotension that may occur.

Provide comfort measures to help the patient tolerate drug effects (e.g., small, frequent meals; access to bathroom facilities; safety precautions if CNS effects occur environmental control; appropriate skin care needed; analgesics as needed).

Calcium channel blockers These agents prevent the movement of calcium into the cardiac and smooth muscle cells when the cells are stimulated.

These agents prevent the movement of calcium into the cardiac and smooth muscle cells when the cells are stimulated.

Calcium channel blockers This blocking of calcium will interfere with the muscle cell's ability to contract, leading to a loss of smooth muscle tone, vasodilation, and a decrease in peripheral resistance . These effects will decrease blood pressure, cardiac workload, and myocardial oxygen consumption .

This blocking of calcium will interfere with the muscle cell's ability to contract, leading to a loss of smooth muscle tone, vasodilation, and a decrease in peripheral resistance .

These effects will decrease blood pressure, cardiac workload, and myocardial oxygen consumption .

Calcium channel blockers Calcium channel blockers are very effective in the treatment of angina because they decrease the cardiac workload.

Calcium channel blockers are very effective in the treatment of angina because they decrease the cardiac workload.

Calcium channel blockers Pharmacodynamics: Mechanism of action Calcium channel blockers inhibit the movement of calcium ions across the membranes of myocardial and arterial muscle cells, altering the action potential and blocking muscle cell contraction. This effect will depress myocardial contractility, slow cardiac impulse formation in the conductive tissues, and relax and dilate arteries, causing a fall in blood pressure and a decrease in venous return.

Pharmacodynamics: Mechanism of action

Calcium channel blockers inhibit the movement of calcium ions across the membranes of myocardial and arterial muscle cells, altering the action potential and blocking muscle cell contraction.

This effect will depress myocardial contractility, slow cardiac impulse formation in the conductive tissues, and relax and dilate arteries, causing a fall in blood pressure and a decrease in venous return.

Calcium channel blockers The calcium channel blockers that are used in the treatment of hypertension include the following: The “-dipine” and others Diltiazem (Cardizem, Tiamate) Verapamil Amlodipine (Norvasc) Felodipine (Plendil) Isredipine (DynaCirc) Nicardipine(Cardene) Nifedipine (CALCIBLOC, Procardia XL)-prototype! Nisoldipine (Sular)

The calcium channel blockers that are used in the treatment of hypertension include the following:

The “-dipine” and others

Diltiazem (Cardizem, Tiamate)

Verapamil

Amlodipine (Norvasc)

Felodipine (Plendil)

Isredipine (DynaCirc)

Nicardipine(Cardene)

Nifedipine (CALCIBLOC, Procardia XL)-prototype!

Nisoldipine (Sular)

Calcium channel blockers CONTRAINDICATION and PRECAUTIONS These drugs are contraindicated in the presence of allergy to any of these drugs With heart block or sick sinus syndrome because these could be exacerbated by the conduction-slowing effects of these drugs With renal and hepatic dysfunction, which could alter the metabolism and excretion of these drugs; and with pregnancy and lactation because of the potential for adverse effects on the fetus and neonate.

CONTRAINDICATION and PRECAUTIONS

These drugs are contraindicated in the presence of allergy to any of these drugs

With heart block or sick sinus syndrome because these could be exacerbated by the conduction-slowing effects of these drugs

With renal and hepatic dysfunction, which could alter the metabolism and excretion of these drugs; and with pregnancy and lactation because of the potential for adverse effects on the fetus and neonate.

Calcium channel blockers Pharmacodynamics: the ADVERSE EFFECTS The adverse effects associated with these drugs are related to their effects on cardiac output and on smooth muscle. CNS effects include dizziness , lightheadedness, headache, and fatigue. GI problems can include nausea and hepatic injury related to direct toxic effects hepatic cells. Cardiovascular effects include hypotension, bradycardia, peripheral edema, and heart block . Skin flushing and rash may also occur

Pharmacodynamics: the ADVERSE EFFECTS

The adverse effects associated with these drugs are related to their effects on cardiac output and on smooth muscle.

CNS effects include dizziness , lightheadedness, headache, and fatigue.

GI problems can include nausea and hepatic injury related to direct toxic effects hepatic cells.

Cardiovascular effects include hypotension, bradycardia, peripheral edema, and heart block . Skin flushing and rash may also occur

Calcium channel blockers Pharmacodynamics: The main use of calcium channel blockers is the treatment of angina Also in hypertension Also in vascular spasm= Raynauds

Pharmacodynamics:

The main use of calcium channel blockers is the treatment of angina

Also in hypertension

Also in vascular spasm= Raynauds

Calcium channel blockers IMPLEMENTATION Monitor blood pressure carefully while patient is on therapy because of increased hypotensive episodes If possible, obtain serial ECG tracing Provide comfort measures to help patient tolerate drug effects- includes serving small frequent feedings and safety precaution due to hypotension and dizziness

IMPLEMENTATION

Monitor blood pressure carefully while patient is on therapy because of increased hypotensive episodes

If possible, obtain serial ECG tracing

Provide comfort measures to help patient tolerate drug effects- includes serving small frequent feedings and safety precaution due to hypotension and dizziness

Calcium channel blockers IMPLEMENTATION Provide health teaching as to drug name, dosage, administration, side effects and warning manifestations to report

IMPLEMENTATION

Provide health teaching as to drug name, dosage, administration, side effects and warning manifestations to report

The Vasodilators Vasodilators produce relaxation of the vascular smooth muscle, decreasing peripheral resistance and reducing blood pressure. They cause the reflex tachycardia that occurs when blood pressure drops

Vasodilators produce relaxation of the vascular smooth muscle, decreasing peripheral resistance and reducing blood pressure.

They cause the reflex tachycardia that occurs when blood pressure drops

The Vasodilators The vasodilators are used to treat severe hypertension

The vasodilators are used to treat severe hypertension

Vasodilators Diazoxide (Hyperstat) Hydralazine (Apresoline) Minoxidil (Loniten) Sodium Nitroprusside (Nitropress) Tolazoline (Priscoline)

Diazoxide (Hyperstat)

Hydralazine (Apresoline)

Minoxidil (Loniten)

Sodium Nitroprusside (Nitropress)

Tolazoline (Priscoline)

Vasodilators Pharmacodynamics: mechanism of action of the vasodilators The vasodilators act directly on vascular smooth muscle to cause muscle relaxation, leading to vasodilation and drop in blood pressure . They are indicated for the treatment of severe hypertension that has not responded to other therapy.

Pharmacodynamics: mechanism of action of the vasodilators

The vasodilators act directly on vascular smooth muscle to cause muscle relaxation, leading to vasodilation and drop in blood pressure .

They are indicated for the treatment of severe hypertension that has not responded to other therapy.

Vasodilators Contraindications and Precautions The vasodilators are contraindicated in the presence of known allergy to the drug; with pregnancy and lactation because of the potential for adverse effects on the fetus and neonate; and with any condition that could be exacerbated by a sudden fall in blood pressure, such as cerebral insufficiency.

Contraindications and Precautions

The vasodilators are contraindicated in the presence of known allergy to the drug; with pregnancy and lactation because of the potential for adverse effects on the fetus and neonate; and with any condition that could be exacerbated by a sudden fall in blood pressure, such as cerebral insufficiency.

Vasodilators Pharmacodynamics: the adverse effects of the vasodilators CNS- dizziness , anxiety, headache CVS- reflex tachycardia , CHF, chest pain, edema; skin rash, lesions (abnormal hair growth with minoxidil), hypotension GI upset, nausea, and vomiting

Pharmacodynamics: the adverse effects of the vasodilators

CNS- dizziness , anxiety, headache

CVS- reflex tachycardia , CHF, chest pain, edema; skin rash, lesions (abnormal hair growth with minoxidil), hypotension

GI upset, nausea, and vomiting

Vasodilators Pharmacodynamics: the adverse effects of the vasodilators Cyanide toxicity (dyspnea, headache, vomiting, dizziness, ataxia, loss of consciousness, imperceptible pulse, absent reflexes, dilated pupils, pink color, distant heart sounds, shallow breathing) may occur with nitroprusside , which is metabolized to cyanide and which also suppresses iodine uptake and can cause hypothyroidism.

Pharmacodynamics: the adverse effects of the vasodilators

Cyanide toxicity (dyspnea, headache, vomiting, dizziness, ataxia, loss of consciousness, imperceptible pulse, absent reflexes, dilated pupils, pink color, distant heart sounds, shallow breathing) may occur with nitroprusside , which is metabolized to cyanide and which also suppresses iodine uptake and can cause hypothyroidism.

Vasodilators IMPLEMENTATION Encourage the patient to implement lifestyle changes, including weight loss, smoking cessation, decrease in alcohol and salt in the diet, and increased exercise, to increase the effectiveness of antihypertensive therapy. Monitor blood pressure closely during administration to evaluate for effectiveness and to ensure quick response if blood pressure falls rapidly or too much .

IMPLEMENTATION

Encourage the patient to implement lifestyle changes, including weight loss, smoking cessation, decrease in alcohol and salt in the diet, and increased exercise, to increase the effectiveness of antihypertensive therapy.

Monitor blood pressure closely during administration to evaluate for effectiveness and to ensure quick response if blood pressure falls rapidly or too much .

Vasodilators IMPLEMENTATION Monitor blood glucose and serum electrolytes to avoid potentially serious adverse effects. Monitor the patient carefully in any situation that might lead to a drop in fluid volume (e.g., excessive sweating, vomiting, diarrhea, dehydration) to detect and treat excessive hypotension that may occur.

IMPLEMENTATION

Monitor blood glucose and serum electrolytes to avoid potentially serious adverse effects.

Monitor the patient carefully in any situation that might lead to a drop in fluid volume (e.g., excessive sweating, vomiting, diarrhea, dehydration) to detect and treat excessive hypotension that may occur.

Vasodilators IMPLEMENTATION Provide comfort measures to help the patient tolerate drug effects (e.g., small, frequent meals, access to bathroom facilities safety precaution if CNS effects occur, environmental control, appropriate skin care as needed, analgesic as needed). Provide thorough patient teaching Offer support and encouragement to deal with the diagnosis drug regimen.

IMPLEMENTATION

Provide comfort measures to help the patient tolerate drug effects (e.g., small, frequent meals, access to bathroom facilities safety precaution if CNS effects occur, environmental control, appropriate skin care as needed, analgesic as needed).

Provide thorough patient teaching

Offer support and encouragement to deal with the diagnosis drug regimen.

Drugs for the Treatment of Congestive Heart Failure Vasodilators- Nitrates that act to directly relax vascular muscle tone and cause decrease in blood pressure with pooling of blood in the veins. The preload and afterload will be decreased ACE inhibitors- are agents that block the conversion of angiotensin I to angiotensin II. The result is blockage of the vasoconstriction and decreased blood volume. The afterload will be decreased. Diuretics are employed to decrease the blood volume, which decreases the venous return and the blood pressure. The results are decreased preload and decreased afterload.

Vasodilators- Nitrates that act to directly relax vascular muscle tone and cause decrease in blood pressure with pooling of blood in the veins. The preload and afterload will be decreased

ACE inhibitors- are agents that block the conversion of angiotensin I to angiotensin II. The result is blockage of the vasoconstriction and decreased blood volume. The afterload will be decreased.

Diuretics are employed to decrease the blood volume, which decreases the venous return and the blood pressure. The results are decreased preload and decreased afterload.

Drugs for the Treatment of Congestive Heart Failure Beta stimulators will stimulate the beta receptors in the sympathetic nervous system, increasing the myocardial contraction- called positive inotropic effect. Cardiotonic drugs- these agents affect the INTRACELLULAR calcium levels in the heart muscles leading to increased contractility . The result is increased cardiac output, increased renal blood flow, increased perfusion and increased urine formation. The cardiotonic drugs are: the cardiac glycosides and the phosphodiesterase inhibitors.

Beta stimulators will stimulate the beta receptors in the sympathetic nervous system, increasing the myocardial contraction- called positive inotropic effect.

Cardiotonic drugs- these agents affect the INTRACELLULAR calcium levels in the heart muscles leading to increased contractility . The result is increased cardiac output, increased renal blood flow, increased perfusion and increased urine formation. The cardiotonic drugs are: the cardiac glycosides and the phosphodiesterase inhibitors.

The cardiac glycosides These are agents extracted from the foxglove plant. They are available in oral and parenteral preparations. The following are the cardiac glycosides: Digoxin (Lanoxin) Digitoxin (Crystodigin) Ouabain

These are agents extracted from the foxglove plant. They are available in oral and parenteral preparations. The following are the cardiac glycosides:

Digoxin (Lanoxin)

Digitoxin (Crystodigin)

Ouabain

The cardiac glycosides Pharmacodynamics: the Mechanism of action They increase the level of CALCIUM inside the cell by inhibiting the Sodium-Potassium pump . More calcium will accumulate inside the cell during cellular depolarization.

Pharmacodynamics: the Mechanism of action

They increase the level of CALCIUM inside the cell by inhibiting the Sodium-Potassium pump .

More calcium will accumulate inside the cell during cellular depolarization.

The cardiac glycosides Positive inotropic Effect- the myocardium will contract forcefully Increased cardiac output Increased blood flow to the body organs like the kidney and liver Negative chronotropic effect- the heart rate is slowed due to decreased rate of cellular repolarization Bradycardia Decreased conduction velocity through the AV node

Positive inotropic Effect- the myocardium will contract forcefully

Increased cardiac output

Increased blood flow to the body organs like the kidney and liver

Negative chronotropic effect- the heart rate is slowed due to decreased rate of cellular repolarization

Bradycardia

Decreased conduction velocity through the AV node

The cardiac glycosides Clinical Use of the cardiac glycosides Treatment of congestive heart failure Treatment of dysrhythmias like atrial flutter, atrial fibrillation and paroxysmal atrial tachycardia

Clinical Use of the cardiac glycosides

Treatment of congestive heart failure

Treatment of dysrhythmias like atrial flutter, atrial fibrillation and paroxysmal atrial tachycardia

The cardiac glycosides Contraindications and Precautions Contraindicated in the presence of allergy to any cardiac glycoside. They are NOT given to patients with ventricular dysrhythmias, heart block or sick sinus syndrome, aortic stenosis, acute MI, electrolyte imbalances ( HYPOKALEMIA, HYPOMAGNESEMIA and HYPERCALCEMIA ) and renal failure (may cause accumulation of drug)

Contraindications and Precautions

Contraindicated in the presence of allergy to any cardiac glycoside.

They are NOT given to patients with ventricular dysrhythmias, heart block or sick sinus syndrome, aortic stenosis, acute MI, electrolyte imbalances ( HYPOKALEMIA, HYPOMAGNESEMIA and HYPERCALCEMIA ) and renal failure (may cause accumulation of drug)

The cardiac glycosides Pharmacodynamics: the Adverse Effects of the Cardiac glycosides CNS- Headache, weakness , seizures and drowsiness CVS- arrhythmias If digitalis toxicity is developing- the nurse must assess the following adverse effects: Anorexia, nausea and vomiting, visual changes- YELLOW halo around an object, and palpitations or very slow heart rate

Pharmacodynamics: the Adverse Effects of the Cardiac glycosides

CNS- Headache, weakness , seizures and drowsiness

CVS- arrhythmias

If digitalis toxicity is developing- the nurse must assess the following adverse effects: Anorexia, nausea and vomiting, visual changes- YELLOW halo around an object, and palpitations or very slow heart rate

The cardiac glycosides Drug-Drug Interactions If taken with Verapamil, Amniodarone, quinidine, quinine, erythromycin and tetracyclines- can increase the risk of INCREASED effects of digitalis. If taken with potassium-losing diuretics like furosemide- can INCREASE the risk of toxicity and arrhythmias. Potassium replacement must be given. If given with cholestyramine, charcoal and colestipol- can cause impaired absorption of digitalis

Drug-Drug Interactions

If taken with Verapamil, Amniodarone, quinidine, quinine, erythromycin and tetracyclines- can increase the risk of INCREASED effects of digitalis.

If taken with potassium-losing diuretics like furosemide- can INCREASE the risk of toxicity and arrhythmias. Potassium replacement must be given.

If given with cholestyramine, charcoal and colestipol- can cause impaired absorption of digitalis

The cardiac glycosides Implementation Administer the initial rapid digitalization and loading dose as ordered intravenously Monitor the APICAL pulse rate for ONE full minute before administering the drug. Withhold the drug if Less than 60 in adults Less than 90 in infants More than 110 in adults Retake pulse in one hour, if pulses remain abnormal, refer!

Implementation

Administer the initial rapid digitalization and loading dose as ordered intravenously

Monitor the APICAL pulse rate for ONE full minute before administering the drug. Withhold the drug if

Less than 60 in adults

Less than 90 in infants

More than 110 in adults

Retake pulse in one hour, if pulses remain abnormal, refer!

The cardiac glycosides Implementation Check the spelling of the drug- DIGOXIN is different from DIGITOXIN! Check the dosage preparation and the level of digitalis in the blood. ( Therapeutic level is 0.5 to 2.0 nanograms/mL ) Administer intravenous drug VERY slow IV over 5 minutes to avoid arrhythmias. Do NOT administer intramuscularly because it can cause severe pain

Implementation

Check the spelling of the drug- DIGOXIN is different from DIGITOXIN!

Check the dosage preparation and the level of digitalis in the blood. ( Therapeutic level is 0.5 to 2.0 nanograms/mL )

Administer intravenous drug VERY slow IV over 5 minutes to avoid arrhythmias. Do NOT administer intramuscularly because it can cause severe pain

The cardiac glycosides Implementation Administer the drug without food if possible to avoid delayed absorption . Weight patient daily to determine fluid retention Maintain emergency equipment and drugs= Potassium salts, Lidocaine for arrhythmias, phenytoin for seizures, atropine for bradycardia. Provide comfort measures- small, frequent meals, adequate lighting, comfortable position, rest periods and safety precautions

Implementation

Administer the drug without food if possible to avoid delayed absorption . Weight patient daily to determine fluid retention

Maintain emergency equipment and drugs= Potassium salts, Lidocaine for arrhythmias, phenytoin for seizures, atropine for bradycardia.

Provide comfort measures- small, frequent meals, adequate lighting, comfortable position, rest periods and safety precautions

The cardiac glycosides Implementation Provide health teaching- drug name, action, dosage and side effects. Advise the patient to report any of the following: Visual changes, rapid weight gain, unusually low heart rate, persistent nausea, vomiting and anorexia Monitor serum potassium level

Implementation

Provide health teaching- drug name, action, dosage and side effects. Advise the patient to report any of the following: Visual changes, rapid weight gain, unusually low heart rate, persistent nausea, vomiting and anorexia

Monitor serum potassium level

The cardiac glycosides Evaluation Evaluate effectiveness of the drug: Increased urine output Normal heart rate in arrhythmia

Evaluation

Evaluate effectiveness of the drug:

Increased urine output

Normal heart rate in arrhythmia

The Antianginal drugs In the treatment of angina, three agents are commonly employed- Organic nitrates Beta-blockers and Calcium-channel blockers. The benefits of the drugs lie in their different mode of action.

In the treatment of angina, three agents are commonly employed-

Organic nitrates

Beta-blockers and

Calcium-channel blockers.

The benefits of the drugs lie in their different mode of action.

The Antianginal drugs The nitrates can cause vasodilatation of the veins and to some extent, coronary artery

The nitrates can cause vasodilatation of the veins and to some extent, coronary artery

The Antianginal drugs Beta-blockers will decrease the heart rate

Beta-blockers will decrease the heart rate

The Antianginal drugs Calcium-channel blockers will decrease force of contraction leading to a decreased myocardial workload and demand. They can also produce vasodilation

Calcium-channel blockers will decrease force of contraction leading to a decreased myocardial workload and demand.

They can also produce vasodilation

The Antianginal drugs Anti anginal drugs are effective if the chest pain is relieved

Anti anginal drugs are effective if the chest pain is relieved

The Organic nitrates These agents are simple nitric and nitrous acid esters of alcohols. Being alcohol, they differ in their volatility. The following are the nitrates commonly used: Nitroglycerin- A moderately volatile nitrate Isosorbide Dinitrate (Isordil) or mononitrate Amyl nitrate- an extremely volatile nitrate

These agents are simple nitric and nitrous acid esters of alcohols. Being alcohol, they differ in their volatility. The following are the nitrates commonly used:

Nitroglycerin- A moderately volatile nitrate

Isosorbide Dinitrate (Isordil) or mononitrate

Amyl nitrate- an extremely volatile nitrate

The Organic nitrates Nitroglycerin This agent is supplied in oral, spray, transdermal and ointment preparations.

Nitroglycerin

This agent is supplied in oral, spray, transdermal and ointment preparations.

The Organic nitrates Pharmacodynamics: the mechanism of action Nitroglycerin relaxes the smooth muscles in the vascular system by its conversion to nitric oxide, a chemical mediator in the body that relaxes smooth muscles.

Pharmacodynamics: the mechanism of action

Nitroglycerin relaxes the smooth muscles in the vascular system by its conversion to nitric oxide, a chemical mediator in the body that relaxes smooth muscles.

The Organic nitrates Administered nitrates Increased nitrates in the blood increased formation of nitric oxide increased cGMP formation increased dephosphorylation of myosin Vascular smooth muscle relaxation vasodilatation

Administered nitrates

Increased nitrates in the blood

increased formation of nitric oxide

increased cGMP formation

increased dephosphorylation of myosin

Vascular smooth muscle relaxation

vasodilatation

The Organic nitrates Pharmacokinetics- absorption to excretion It can be given orally, parenterally and topically. The onset of action of nitroglycerin is more than 1 hour. Because significant first-pass hepatic effect, Nitroglycerin is given SUBLINGUALY.

Pharmacokinetics- absorption to excretion

It can be given orally, parenterally and topically.

The onset of action of nitroglycerin is more than 1 hour.

Because significant first-pass hepatic effect, Nitroglycerin is given SUBLINGUALY.

The Organic nitrates Pharmacodynamics: Side effects and adverse effects HEADACHE is the most common effect of nitroglycerin. CVS- postural Hypotension, facial flushing, tachycardia TOLERANCE - the tolerance to the actions of nitrates develop rapidly. This can be managed by providing a day of abstinence.

Pharmacodynamics: Side effects and adverse effects

HEADACHE is the most common effect of nitroglycerin.

CVS- postural Hypotension, facial flushing, tachycardia

TOLERANCE - the tolerance to the actions of nitrates develop rapidly. This can be managed by providing a day of abstinence.

The Nitrates Implementation Monitor vital signs, especially watchful for hypotensive episodes Advise patient to remain supine or sit on a chair when taking the nitroglycerin for the first time. Emphasize that he should change his position slowly or rise from bed slowly to avoid orthostatic Hypotension Offer sips of water before giving sublingual nitroglycerin because dryness may inhibit drug absorption

Implementation

Monitor vital signs, especially watchful for hypotensive episodes

Advise patient to remain supine or sit on a chair when taking the nitroglycerin for the first time. Emphasize that he should change his position slowly or rise from bed slowly to avoid orthostatic Hypotension

Offer sips of water before giving sublingual nitroglycerin because dryness may inhibit drug absorption

The Nitrates Implementation Apply nitroglycerin ointment to the designated mark on paper. The nurse should remove any excess ointment on the skin from the previous dose. She should NEVER USE her bare fingers because the drug can be absorbed, utilize gloves or tongue blades instead.

Implementation

Apply nitroglycerin ointment to the designated mark on paper.

The nurse should remove any excess ointment on the skin from the previous dose.

She should NEVER USE her bare fingers because the drug can be absorbed, utilize gloves or tongue blades instead.

The Nitrates Implementation Apply nitroglycerin patch to an area with few hairs. Never touch the medication portion. The patch and the ointment should NOT be applied near the area for defibrillation because explosion and skin burns may result

Implementation

Apply nitroglycerin patch to an area with few hairs. Never touch the medication portion.

The patch and the ointment should NOT be applied near the area for defibrillation because explosion and skin burns may result

The Nitrates IMPLEMENTATION Emphasize that tolerance to the nitroglycerin can occur. If the medication cannot relieve the pain, report to the hospital immediately.

IMPLEMENTATION

Emphasize that tolerance to the nitroglycerin can occur.

If the medication cannot relieve the pain, report to the hospital immediately.

The Nitrates IMPLEMENTATION Provide client health teaching- the sublingual nitroglycerin tablet is USED if chest pain occurs The dose may be repeated if pain is unrelieved within 5 minutes. Repeat the medication administration if the pain has not yet subsided . DO NOT give more than 3 tablets! !! If chest pain persists for more than 15 minutes, hospital consult should be done immediately.

IMPLEMENTATION

Provide client health teaching- the sublingual nitroglycerin tablet is USED if chest pain occurs

The dose may be repeated if pain is unrelieved within 5 minutes.

Repeat the medication administration if the pain has not yet subsided .

DO NOT give more than 3 tablets! !! If chest pain persists for more than 15 minutes, hospital consult should be done immediately.

The Nitrates IMPLEMENTATION Instruct the client to avoid alcohol while taking nitroglycerin to avoid potentiating the hypotensive effect of the medication If beta blockers and calcium-channel blockers are given, instruct the patients to consult the physician before discontinuing the medication

IMPLEMENTATION

Instruct the client to avoid alcohol while taking nitroglycerin to avoid potentiating the hypotensive effect of the medication

If beta blockers and calcium-channel blockers are given, instruct the patients to consult the physician before discontinuing the medication

The Nitrates IMPLEMENTATION Other components of health teaching for home self-administration: If taking Sublingual Nitroglycerin, the patient should be instructed to place the tablet under the tongue for quick absorption. A burning sensation/biting/stinging sensation may indicate that the tablet is FRESH ! Store the tablet in a dark container , keep it away from heat and direct sunlight to avoid lessening the potency

IMPLEMENTATION

Other components of health teaching for home self-administration:

If taking Sublingual Nitroglycerin, the patient should be instructed to place the tablet under the tongue for quick absorption.

A burning sensation/biting/stinging sensation may indicate that the tablet is FRESH !

Store the tablet in a dark container , keep it away from heat and direct sunlight to avoid lessening the potency

The Nitrates IMPLEMENTATION Other components of health teaching for home self-administration: HEADACHES are common in the initial period of nitroglycerin therapy. Advise patient to take PARACETAMOL for relief The nitroglycerin patch is applied once a day, usually in the morning. The sites should be rotated, in the chest, arms and thighs avoiding hairy areas.

IMPLEMENTATION

Other components of health teaching for home self-administration:

HEADACHES are common in the initial period of nitroglycerin therapy. Advise patient to take PARACETAMOL for relief

The nitroglycerin patch is applied once a day, usually in the morning. The sites should be rotated, in the chest, arms and thighs avoiding hairy areas.

The Nitrates IMPLEMENTATION Other components of health teaching for home self-administration: Position supine with elevated legs to manage Hypotension. Nitroglycerin tablet can be taken prophylactically in situations where chest pain is anticipated- Sex, exercise, etc.. If patient is taking beta blockers, instruct how to obtain heart rate in a minute

IMPLEMENTATION

Other components of health teaching for home self-administration:

Position supine with elevated legs to manage Hypotension.

Nitroglycerin tablet can be taken prophylactically in situations where chest pain is anticipated- Sex, exercise, etc..

If patient is taking beta blockers, instruct how to obtain heart rate in a minute

Drugs for Shock Dopamine This is a sympathomimetic drug often used to treat Hypotension in shock states that are not caused by Hypovolemia. This drug is an immediate precursor of nor-epinephrine, occurs naturally in the CNS basal ganglia where it functions as a neurotransmitter.

Dopamine

This is a sympathomimetic drug often used to treat Hypotension in shock states that are not caused by Hypovolemia.

This drug is an immediate precursor of nor-epinephrine, occurs naturally in the CNS basal ganglia where it functions as a neurotransmitter.

Drugs for Shock Dopamine Pharmacodynamics: It can activate the alpha and beta adrenergic receptor depending upon the concentration. It stimulates receptors to cause cardiac stimulation and renal vasodilation . The dose range is 1-20 micrograms/kg/min

Dopamine

Pharmacodynamics: It can activate the alpha and beta adrenergic receptor depending upon the concentration. It stimulates receptors to cause cardiac stimulation and renal vasodilation .

The dose range is 1-20 micrograms/kg/min

Drugs for Shock Dopamine Pharmacokinetics: Dopamine is administered IV, excreted in the urine. At low dose ( 1-2 micrograms ), dopamine DILATES the renal and mesenteric blood vessels producing an increase output (dopaminergic effect)

Dopamine

Pharmacokinetics: Dopamine is administered IV, excreted in the urine.

At low dose ( 1-2 micrograms ), dopamine DILATES the renal and mesenteric blood vessels producing an increase output (dopaminergic effect)

Drugs for Shock Dopamine At moderate dose of 2-10 micrograms, dopamine enhance cardiac output by increasing heart rate ( beta 1-adrenergic effect) and elevates blood pressure through peripheral vasoconstriction (alpha adrenergic effect)

Dopamine

At moderate dose of 2-10 micrograms, dopamine enhance cardiac output by increasing heart rate ( beta 1-adrenergic effect) and elevates blood pressure through peripheral vasoconstriction (alpha adrenergic effect)

Drugs for Shock Dopamine At higher doses of more than 10 micrograms- vasoconstriction of all vessels will predominate that can lead to diminished tissue perfusion

Dopamine

At higher doses of more than 10 micrograms- vasoconstriction of all vessels will predominate that can lead to diminished tissue perfusion

Drugs for Shock Dopamine Dopamine is indicated to treat Hypotension, to increase heart rate and to increase urine output (given less than 5 mg/kg/min) The nurse typically prepares the dopamine drip- dopamine (at a concentration of 400-800 mg) is mixed in 250 mL D5W and administered as drip via an infusion pump for precise dosage administration. Sodium bicarbonate will inactivate the dopamine

Dopamine

Dopamine is indicated to treat Hypotension, to increase heart rate and to increase urine output (given less than 5 mg/kg/min)

The nurse typically prepares the dopamine drip- dopamine (at a concentration of 400-800 mg) is mixed in 250 mL D5W and administered as drip via an infusion pump for precise dosage administration.

Sodium bicarbonate will inactivate the dopamine

Drugs for Shock Dopamine Pharmacodynamics: side effects- Tachycardia hypertension ectopic beats, angina dysrhythmias, myocardial ischemia, nausea and vomiting.

Dopamine

Pharmacodynamics: side effects- Tachycardia

hypertension

ectopic beats, angina

dysrhythmias, myocardial ischemia, nausea and vomiting.

Drugs for Shock Dopamine: Nursing consideration Check the IV site hourly for signs of drug infiltration of dopamine, which can cause severe tissue necrosis. Phentolamine should be infiltrated in multiple areas to reduce tissue damage. Drug is effective if Urine output is increased and BP is increased

Dopamine: Nursing consideration

Check the IV site hourly for signs of drug infiltration of dopamine, which can cause severe tissue necrosis.

Phentolamine should be infiltrated in multiple areas to reduce tissue damage.

Drug is effective if Urine output is increased and BP is increased

Anti-Arrhythmias Arrhythmias (sometimes called Dysrhythmias) are conduction dysfunctions caused by abnormalities in impulse generation or impaired transmission of the impulses. They are simply deviations from the normal rate or pattern of the heartbeat.

Arrhythmias (sometimes called Dysrhythmias) are conduction dysfunctions caused by abnormalities in impulse generation or impaired transmission of the impulses.

They are simply deviations from the normal rate or pattern of the heartbeat.

Anti-Arrhythmias Four things may happen during arrhythmias: The heart will beat too FAST (tachycardia, either the atrium or the ventricle) The heart will beat too slow (bradycardia) The heart will respond to other impulses generated by the cardiac cells (other than the SA node) The heat will respond to impulses traveling along extra pathways

Four things may happen during arrhythmias:

The heart will beat too FAST (tachycardia, either the atrium or the ventricle)

The heart will beat too slow (bradycardia)

The heart will respond to other impulses generated by the cardiac cells (other than the SA node)

The heat will respond to impulses traveling along extra pathways

Anti-Arrhythmias Anti-arrhythmic agents are given to modify impulse generation and conduction. The desired action of these antidysrhythmics is to restore the cardiac rhythm to normal. They affect the action potential of the cardiac cells, altering their automaticity, conductivity, or BOTH

Anti-arrhythmic agents are given to modify impulse generation and conduction.

The desired action of these antidysrhythmics is to restore the cardiac rhythm to normal.

They affect the action potential of the cardiac cells, altering their automaticity, conductivity, or BOTH

Anti-Arrhythmias Because the anti-arrhythmic drugs affect the conduction system, they also can produce ARRHYTHMIAS! They are also Pro-Arrhythmics!

Because the anti-arrhythmic drugs affect the conduction system, they also can produce ARRHYTHMIAS!

They are also Pro-Arrhythmics!

Anti-Arrhythmias The classes of anti-arrhythmic agents: Class 1 agents - are fast SODIUM channel blockers that affects the depolarization phase. Class 2 agents- are BETA blockers that affect the depolarization. Class 3 agents- are POTASSIUM channel blockers that diminish the outward potassium current during repolarization of cardiac cells. Class 4 agents- are calcium channel blockers that decrease the calcium influx into the specialized cardiac muscle cells causing slowed conduction

The classes of anti-arrhythmic agents:

Class 1 agents - are fast SODIUM channel blockers that affects the depolarization phase.

Class 2 agents- are BETA blockers that affect the depolarization.

Class 3 agents- are POTASSIUM channel blockers that diminish the outward potassium current during repolarization of cardiac cells.

Class 4 agents- are calcium channel blockers that decrease the calcium influx into the specialized cardiac muscle cells causing slowed conduction

Anti-Arrhythmias The classes of anti-arrhythmic agents: Class 1 agents - Class 1 A- Quinidine, Procainamide, Disopyramide, Moricizine Class 1 B- Lidocaine, Mexiletine, Tocainide Class 1 C- Encainide, Flecainide, propafenone

The classes of anti-arrhythmic agents:

Class 1 agents -

Class 1 A- Quinidine, Procainamide, Disopyramide, Moricizine

Class 1 B- Lidocaine, Mexiletine, Tocainide

Class 1 C- Encainide, Flecainide, propafenone

Anti-Arrhythmias The classes of anti-arrhythmic agents: Class 2 agents- are BETA blockers that affect the depolarization. They decrease the conduction velocity, automaticity and recovery time. Examples are: Propranolol, Metoprolol, pindolol, acebutol and esmolol

The classes of anti-arrhythmic agents:

Class 2 agents- are BETA blockers that affect the depolarization. They decrease the conduction velocity, automaticity and recovery time. Examples are: Propranolol, Metoprolol, pindolol, acebutol and esmolol

Anti-Arrhythmias The classes of anti-arrhythmic agents: Class 3 agents- are POTASSIUM channel blockers that diminish the outward potassium current during repolarization of cardiac cells. They increase the refractory period and prolong the action potential. Examples are: sotalol, bretylium, amniodarone

The classes of anti-arrhythmic agents:

Class 3 agents- are POTASSIUM channel blockers that diminish the outward potassium current during repolarization of cardiac cells.

They increase the refractory period and prolong the action potential. Examples are: sotalol, bretylium, amniodarone

Anti-Arrhythmias Class 4 agents- are calcium channel blockers that decrease the calcium influx into the specialized cardiac muscle cells causing slowed conduction. They increase the refractory period of the AV node, which decreases the ventricular response. The examples of calcium channel blockers are diltiazem and verapamil

Class 4 agents- are calcium channel blockers that decrease the calcium influx into the specialized cardiac muscle cells causing slowed conduction. They increase the refractory period of the AV node, which decreases the ventricular response.

The examples of calcium channel blockers are diltiazem and verapamil

Anti-Arrhythmias Miscellaneous- digoxin and adenosine

Miscellaneous- digoxin and adenosine

Anti-Arrhythmias General Nursing Process for Anti-arrhythmics Assessment Patient History- the nurse obtains health and drug histories. She should elicit symptoms of shortness of breath, heart palpitations, coughing, chest pain, previous angina or dysrhythmias, and the current medications. Physical Examination- the nurse performs assessment and baseline monitoring Laboratory exams- the nurse obtains ECG results and cardiac markers- CK-MB, AST and LDH)

General Nursing Process for Anti-arrhythmics

Assessment

Patient History- the nurse obtains health and drug histories. She should elicit symptoms of shortness of breath, heart palpitations, coughing, chest pain, previous angina or dysrhythmias, and the current medications.

Physical Examination- the nurse performs assessment and baseline monitoring

Laboratory exams- the nurse obtains ECG results and cardiac markers- CK-MB, AST and LDH)

Anti-Arrhythmias Nursing Diagnoses Alteration on perfusion: decreased cardiac output Alteration in thought processes and sensory-perceptual alteration Anxiety related to irregular heartbeat Risk for activity intolerance Risk for injury related to CNS effects Knowledge deficit regarding drug therapy

Nursing Diagnoses

Alteration on perfusion: decreased cardiac output

Alteration in thought processes and sensory-perceptual alteration

Anxiety related to irregular heartbeat

Risk for activity intolerance

Risk for injury related to CNS effects

Knowledge deficit regarding drug therapy

Anti-Arrhythmias Planning The client will no longer experience abnormal cardiac rhythm The client will comply with the drug regimen

Planning

The client will no longer experience abnormal cardiac rhythm

The client will comply with the drug regimen

Anti-Arrhythmias Implementation Monitor Vital signs especially BP and HR. Patient can develop Hypotension Administer the parenteral drugs slow IV for a period of 2-3 minutes Monitor ECG for abnormal patterns and report findings. Instruct to report palpitations and abnormal cardiac rate Maintain life support equipment on stand by to treat severe adverse reactions that might occur

Implementation

Monitor Vital signs especially BP and HR. Patient can develop Hypotension

Administer the parenteral drugs slow IV for a period of 2-3 minutes

Monitor ECG for abnormal patterns and report findings.

Instruct to report palpitations and abnormal cardiac rate

Maintain life support equipment on stand by to treat severe adverse reactions that might occur

Anti-Arrhythmias Implementation Establish safety precautions- side rails, lighting, and noise control. Provide client teaching. Instruct the client to take the prescribed drug as ordered. Emphasize the client to avoid alcohol, caffeine and tobacco. Alcohol can intensify the hypotensive effects, caffeine increases the cathecolamine levels and tobacco can promote vasoconstriction. Instruct the client to report side effects including dizziness, faintness, and nausea and vomiting.

Implementation

Establish safety precautions- side rails, lighting, and noise control.

Provide client teaching. Instruct the client to take the prescribed drug as ordered. Emphasize the client to avoid alcohol, caffeine and tobacco.

Alcohol can intensify the hypotensive effects, caffeine increases the cathecolamine levels and tobacco can promote vasoconstriction.

Instruct the client to report side effects including dizziness, faintness, and nausea and vomiting.

Anti-Arrhythmias Evaluation Evaluate the effectiveness of the prescribed anti-dysrhythmic by comparing heart rates with baseline heart rate. Assess the client’s response to the drug. Monitor for adverse effect- sedation, Hypotension, cardiac arrhythmias, respiratory depression, CNS effect. Evaluate the effectiveness of the teaching plan. Monitor the effectiveness of comfort measures and compliance to regimen.

Evaluation

Evaluate the effectiveness of the prescribed anti-dysrhythmic by comparing heart rates with baseline heart rate.

Assess the client’s response to the drug.

Monitor for adverse effect- sedation, Hypotension, cardiac arrhythmias, respiratory depression, CNS effect.

Evaluate the effectiveness of the teaching plan. Monitor the effectiveness of comfort measures and compliance to regimen.